Literature DB >> 17610603

The prevalence of Dientamoeba fragilis in patients with suspected enteroparasitic disease in a metropolitan area in Denmark.

C R Stensvold1, M C Arendrup, K Mølbak, H V Nielsen.   

Abstract

The prevalence of Dientamoeba fragilis in patients from a metropolitan area in Denmark was determined by examination of paired stool samples using two techniques: a formol ethyl-acetate concentration technique with unpreserved faeces and a permanent staining technique on faeces preserved with sodium acetate-acetic acid-formalin (SAF). Using the SAF permanent staining technique and the formol ethyl-acetate concentration technique, 25% and 15% of the specimens, respectively, were parasite-positive. D. fragilis was detected in 12 of the 103 patients, only two of whom harboured other recognised pathogenic parasites. Overall, D. fragilis had a remarkably high prevalence in the metropolitan area of Denmark investigated.

Entities:  

Mesh:

Year:  2007        PMID: 17610603     DOI: 10.1111/j.1469-0691.2007.01760.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  13 in total

1.  Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria.

Authors:  Javed Yakoob; Wasim Jafri; Mohammad Asim Beg; Zaigham Abbas; Shagufta Naz; Muhammad Islam; Rustam Khan
Journal:  Parasitol Res       Date:  2010-06-08       Impact factor: 2.289

Review 2.  Does Dientamoeba fragilis cause diarrhea? A systematic review.

Authors:  Zing-Wae Wong; Kate Faulder; Joan L Robinson
Journal:  Parasitol Res       Date:  2018-02-05       Impact factor: 2.289

3.  A review of the clinical presentation of dientamoebiasis.

Authors:  Damien Stark; Joel Barratt; Tamalee Roberts; Deborah Marriott; John Harkness; John Ellis
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

4.  Development and evaluation of a real-time PCR assay for detection and quantification of blastocystis parasites in human stool samples: prospective study of patients with hematological malignancies.

Authors:  Philippe Poirier; Ivan Wawrzyniak; Aurélie Albert; Hicham El Alaoui; Frédéric Delbac; Valérie Livrelli
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

Review 5.  Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel.

Authors:  Damien Stark; Joel Barratt; Douglas Chan; John T Ellis
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 6.  Enteric protozoa in the developed world: a public health perspective.

Authors:  Stephanie M Fletcher; Damien Stark; John Harkness; John Ellis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

7.  Dientamoeba fragilis in Denmark: epidemiological experience derived from four years of routine real-time PCR.

Authors:  D Röser; J Simonsen; H V Nielsen; C R Stensvold; K Mølbak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-24       Impact factor: 3.267

8.  Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults?

Authors:  Jaap J van Hellemond; Nicky Molhoek; Rob Koelewijn; Pieter J Wismans; Perry J J van Genderen
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-14       Impact factor: 4.077

9.  Genetic diversity of Dientamoeba fragilis isolates of irritable bowel syndrome patients by high-resolution melting-curve (HRM) analysis.

Authors:  Eman M Hussein; Hamdan I Al-Mohammed; Abdalla M Hussein
Journal:  Parasitol Res       Date:  2009-06-19       Impact factor: 2.289

10.  Blastocystis: Genetic diversity and molecular methods for diagnosis and epidemiology.

Authors:  Christen Rune Stensvold
Journal:  Trop Parasitol       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.